EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Potential blocker of SARS-CoV entry and a narrow functionality of its spike protein motifs on Qubevirus platform

Aristide Dzelamonyuy, Augustin Ntemafack, Millie M Georgiadis, Alain Bopda Waffo

Journal of Biological Chemistry · 2025

DOI: 10.1016/j.jbc.2025.110371 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Aristide Dzelamonyuy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Indiana University School of Medicine. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, SARS-CoV-2, Virus Internalization, Antiviral Agents. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, Indiana University, National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted disruption of SARS-CoV entry remains a critical strategy in antiviral therapeutic design. Central to this process is the viral spike (S) protein, which mediates host recognition via interactions with the human angiotensin-converting enzyme 2 (hACE2). Here, we expand our previous work by identifying the smallest active spike (S) protein binding motif (RBSM) and key residues of SARS-CoV (S473-492) that recognize hACE2. Using the Qubevirus (Qβ) platform, we validated five essential residues (L472, N473, N479, D480, and Y491) that are critical for SARS-CoV binding and entry. Qβ phage-displayed RBSM variants disrupted hACE2 recognition and infection initiation. An engineered RBSM insert containing all five mutant residues completely abolished recognition and binding to both hACE2 and anti-RBD antibodies. Furthermore, QβRBSM1 exhibits no cytotoxic effect on HEK293T cells and reduces the infectivity of SARS-CoV pseudovirus in a competitive assay, as a blocker of SARS-CoV entry. In addition, building upon our previous studies, we determined the optimal positioning of a chimera comprising the three epitopes mapped, fused with an LPTEG/Biot-tag at the N-terminus of the Qβ-A1 minor coat protein for anti-S antibody titration. We determined the optimal chimera tag configuration to be epitope 3 (S781-800) fused directly with the A1 at the N terminus, followed by epitope 1 (S441-460), epitope 2 (S601-620), and the tag at the C terminus. This work provides key insights into the druggability of the RBSM for developing SARS-CoV inhibitors and lays the foundation for designing a biosensor for antibody monitoring and a potential subunit vaccine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spike Glycoprotein, CoronavirusSARS-CoV-2Virus InternalizationAntiviral AgentsHumansAngiotensin-Converting Enzyme 2HEK293 CellsAmino Acid MotifsProtein BindingCOVID-19

Stichwörter der Autor:innen

A(1) minor coat proteinACE2Biot-tagLPETGQubevirusSARS-CoVchimeric epitopespike protein

Substanzen

Spike Glycoprotein, CoronavirusAngiotensin-Converting Enzyme 2ACE2 protein, humanspike protein, SARS-CoV-2Antiviral Agents

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, Indiana University School of Medicine.
  • Department of Biochemistry and Molecular Biology, Indiana University School of Medicine. Electronic address: abopdaw@iu.edu.

Förderung

  • NIA NIH HHS
  • Indiana University
  • National Science Foundation
  • Indiana Clinical and Translational Sciences Institute
  • National Science Foundation Directorate for Biological Sciences
  • School of Medicine, Indiana University
  • National Institutes of Health
  • National Institute on Aging

Zitieren

APA

Dzelamonyuy, A., Ntemafack, A., Georgiadis, M. M., & Bopda Waffo, A. (2025). Potential blocker of SARS-CoV entry and a narrow functionality of its spike protein motifs on Qubevirus platform. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.110371

Vancouver

Dzelamonyuy A, Ntemafack A, Georgiadis MM, Bopda Waffo A. Potential blocker of SARS-CoV entry and a narrow functionality of its spike protein motifs on Qubevirus platform. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.110371

BibTeX
@article{Dzelamonyuy2025,
  author = {Dzelamonyuy, Aristide and Ntemafack, Augustin and Georgiadis, Millie M and Bopda Waffo, Alain},
  title = {Potential blocker of SARS-CoV entry and a narrow functionality of its spike protein motifs on Qubevirus platform},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  doi = {10.1016/j.jbc.2025.110371}
}
Kostenlos starten →